Israel Active

Scientists at Bar-Ilan University have used low-level electricity to increase the rate at which daydreams - or spontaneous, self-directed thoughts and associations - occur.  They also discovered that daydreams have a positive effect on task performance.

A new medical innovation, developed at Tel Aviv University’s Center for Nanoscience & Nanotechnology, uses ‘stick it and forget it’ electrodes affixed to the skin, to monitor muscle activity.  Applications include monitoring driver alertness and individuals with neuro-degenerative diseases.

Canada’s federal department responsible for helping Canadians maintain and improve their health, Health Canada, has approved the Exablate Neuro system for the treatment of essential tremor developed by Israel’s Insightec.

The SafeCT-29 solution from Israel’s Medic Vision Imaging Solutions produces high-quality medical scan images but reduces radiation doses by up to 80%.  SafeCT-29 works with any CT scanner and has just been approved by the US FDA.

I reported about Israel’s Check-cap previously () that requires no prior preparation or hospital visit.  After 4 years, trials on 54 participants of its ingestible and disposable low-dose 3D imaging capsule proved safe and well tolerated and detected small and large polyps.

The BBC has just reported that the UK’s National Health Service has approved the funding of patients receiving the pioneering melanoma (skin cancer) treatment developed by Israeli Professor Jacob Schachter. The approval was one of the fastest in NHS history.  The anti-Israel BBC doesn’t mention the Israeli connection, so please read Sheba hospital’s article for details.

I reported previously about Israeli research into bio-ink that could potentially print human organs.  Now two Israeli companies, Nano Dimension and Accelta have successfully lab-tested a proof-of-concept 3D bio-printer.  It may even be able to print stem cells!

Surgeons at Mercy Medical Center at Cedar Rapids, Iowa, have reported that MarginProbe from Israel’s Dune Medical has reduced the number of repeat breast-cancer operations by 75%.  MarginProbe checks accurately that all cancerous tissue has been removed first time.

Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its KIT-302 treatment for osteoarthritis pain and hypertension simultaneously.  Dexcel will mass-produce and market the treatment.

The supplement Cardiomato, from Israel’s Lycored, beat hundreds of high-quality competitor products to win the NutraIngredients Award for Best Finished Product of the Year – Heart Health.  Cardiomato reduces oxidized LDL cholesterol and lowers systolic blood pressure.